Article
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
The Journal of pediatrics - 1 May 2000
Shenoy S, Arnold S, Chatila T
Abstract excerpt
We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
